Iter Investments

Sensorium Therapeutics is a drug discovery platform based in Boston, Massachusetts, that focuses on developing novel FDA-approved psychoactive medicines. Founded in 2021, the company utilizes an artificial intelligence product engine to discover and develop drugs targeting central nervous system diseases. By integrating historical human efficacy data from natural compounds, Sensorium Therapeutics aims to create new medicines characterized by innovative pharmacology and improved clinical success rates. This approach enables pharmaceutical companies to enhance their drug development processes effectively.

Beckley Retreats specializes in virtual integration programs aimed at healing individuals with neurological and psychiatric disorders. The company provides a week-long program that combines scientific insights with the therapeutic benefits of psychedelic retreats. In addition to facilitating safe and legal psychedelic ceremonies, Beckley Retreats offers training and certification for practitioners, ensuring they are equipped to deliver dedicated care. The organization emphasizes a holistic approach to healing, offering a supportive environment along with access to medical care for participants.

Muse has developed brainwave-controlled computing technology and applications that converts brainwaves into digital signals. They have created a hardware and software platform technology that converts brainwaves into digital signals that are fed into a computer. InteraXon then provides consumers with applications that use these brainwaves to perform activities such as meditation, gaming, ADHD assistance, and many others to come. The company was founded in 2007 and is headquartered in Toronto, Ontario.

Fluence offers continuing education and certificate programs in psychedelic integration and psychedelic-assisted therapy. Our programs are designed for licensed professionals and advanced graduate students who have an opportunity to work with patient populations. Although none of our courses have specific prerequisites, a basic working knowledge of the mental health field and practice of psychotherapy is helpful. Our programs are interactive; we engage in discussion, demonstration, self-reflection exercises, and role plays. Some of our classes and programs are reserved for licensed clinicians, but many are open to anyone who wishes to attend.

Quantified Citizen is a mobile health research platform that aims to modernize scientific research by making it more accessible to both citizen scientists and professional researchers. The platform allows users to easily create and participate in behavioral studies using standardized health measures. It features a diverse library of research focused on various health interventions, including topics such as psychedelics and micro-dosing for mental health. By fostering a community of contributors, Quantified Citizen facilitates faster insights into health research and encourages broader participation in scientific discovery.

Psilera is a biopharmaceutical company dedicated to developing innovative therapeutics for neurodegenerative diseases and mental health disorders. The company focuses on creating a new class of neurological medicines, with its lead asset, PSIL-006, being a non-hallucinogenic psilocybin derivative aimed at treating frontotemporal dementia (FTD). Psilera's approach involves repurposing psychoactive natural products to develop next-generation therapies that enhance cognitive function and address mood and substance use disorders. Committed to scientific excellence, Psilera aims to transform the lives of individuals affected by these challenging conditions through its pioneering research and development efforts.